We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dharmacon Establishes Genome-Wide RNAi Global Initiative with Research Institutes

News   Oct 07, 2005

 
Dharmacon Establishes Genome-Wide RNAi Global Initiative with Research Institutes
 
 
 

RELATED ARTICLES

Triple-negative Breast Cancer Influenced by Dual Action of Genes and RNA

News

Women with triple-negative breast cancer could be differentiated from a more common form of the disease by a panel of 17 small RNA molecules.

READ MORE

Compound Kills Chemotherapy-resistant Cancer Cells

News

Study reports the discovery of a compound that is capable of killing chemotherapy-resistant glioblastoma-initiating cells (GICs), raising hopes of producing drugs capable of eradicating refractory tumors with low toxicity.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE